Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant.
The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England.
A personalised immunotherapy treatment will now be available in Scotland for some adults living with an aggressive form of lymphoma.
A targeted combination treatment for patients with a specific type of blood cancer will soon be available on the NHS in Scotland.
Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England.
Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.
A blood test could help predict the risk of complication following a bone marrow transplant in some blood cancer patients, according to a new US study.